http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_695f0309fe0c11c125a8732a2cd61156
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ando Kiyoshi Ando |
| name | Kiyoshi Ando |
| given-name | Kiyoshi |
| organization-name | University, School of Medicine, Kanagawa 3Research Center for Genetic Engineeering and Cell Transplantation, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193 Japan; 4Department of Internal Medicine, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193 Japan Michinori Ogura, Nagoya Daini Red Cross Hospital; Takashi Ishida and Hiroshi Inagaki, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Ryuzo Ueda, Aichi Medical University School of Medicine, Nagoya; Kiyohiko Hatake, Japanese Foundation for Cancer Research; Kensei Tobinai, National Cancer Center Hospital; Shiro Akinaga, Kyowa Hakko Kirin, Tokyo; Masafumi Taniwaki, Kyoto Prefectural University of Medicine, Kyoto; Kiyoshi Ando, Tokai University School of... From the Division of Hematopoiesis, Research Center of Regenerative Medicine, Department of Hematology, Teaching and Research Support Center, Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; and the Central Institute for Experimental Animals, Kawasaki, Kanagawa, Japan. Center for Regenerative Medicine Tokai University School of Medicine Isehara Japan; Department of Hematology–Oncology Tokai University School of Medicine Isehara Japan Department of Hematology/Oncology, Department of Internal Medicine Tokai University School of Medicine Isehara Japan Department of Hematology and Oncology, Tokai University Hospital Isehara Kanagawa Japan Central Institute for Experimental Animals, 1430, Nogawa, Miyamae-ku, Kawasaki, 216-0001 Japan. Division of Hematopoiesis Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Hematology and Oncology Tokai University School of Medicine, Isehara, Kanagawa, Japan Tokai University School of Medicine, Department of Hematology and Oncology. Division of Hematology/Oncology, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan Division of Hematology, Department of Internal Medicine, Tokai University School of Medicine 10Tokai University Hospital, Isehara, Japan Department of Hematology and Oncology, Tokai University School of Medicine , Isehara, Japan Support Center for Medical Research and Education, Tokai University School of Medicine 6 , Isehara , Japan Hematology and Oncology, School of Medicine, Tokai University, Kanagawa, Japan Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine Department of Hematology/Oncology Tokai University Hospital Kanagawa Japan Hematology/Oncology, Tokai University School of Medicine, Isehara Research Center for Regenerative Medicine,; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan; From the Division of Hematology, the Departments of Internal Medicine and Immunology, Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicine, Kanagawa; the Division of Hematology, the Department of Internal Medicine, Keio University School of Medicine, Tokyo; and the Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan. Tokai University School of Medicine Isehara Japan Research Center for Regenerative Medicine and Cancer Stem Cell Tokai University School of Medicine Isehara Kanagawa 259‐1193 Japan From the Research Center for Cell Transplantation, Department of Pediatrics, and the Department of Hematology, Tokai University, School of Medicine, Kanagawa, Japan; JT Inc, Kanagawa, Japan; and the Unit of Transplantation and Clinical Immunology, Claude Bernard University, Pavillon P, Hopital E. Herriot, Lyon, France. Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan;; Department of Hematology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; and Department of Hematology and Oncology, School of Medicine Tokai University Isehara Japan Division of Hematology, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan; Research Center for Regenerative Medicine, Tokai University School of Medicine, Kanagawa, Japan Department of Hematology and Oncology, Tokai University School of Medicine. Department of Hematology and Oncology, Tokai University School of Medicine , Isehara , Japan; Research Center for Regenerative Medicine, Tokai University School of Medicine , Isehara , Japan Division of Hematology and Oncology, Department of Medicine, Tokai University School of Medicine, Isehara-shi, Japan Department of Haematology and Oncology Tokai University School of Medicine Isehara Japan Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan; and *Research Center for Cell Transplantation,; ‡Department of Hematology and Rheumatology, Tokai University, School of Medicine, Kanagawa, Japan; and *Research Center for Cell Transplantation, and Departments of; †Hematology and Takashi Watanabe, Kensei Tobinai, Taro Shibata, and Takashi Terauchi, National Cancer Center Hospital; Kengo Takeuchi, Japanese Foundation for Cancer Research; Shigeru Nawano, International University of Health and Welfare Mita Hospital, Tokyo; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Yasuo Morishima, Aichi Cancer Center Hospital; Tomohiro Kinoshita, Nagoya University Graduate School of Medicine; Michinori Ogura, Nagoya Daini... Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan, Tokai University School of Medicine, Kanagawa, Japan Division of Hematology/Medical Oncology, Departments of Medicine Tokai University School of Medicine, Isehara, Japan Department of Hematology/Oncology, Tokai University School of Medicine, Japan Hematology and Oncology, Tokai University School of Medicine, Japan Division of Hematology/Oncology Department of Internal Medicine Tokai University Hospital Isehara Japan Department of Hematology/Oncology Tokai University, School of Medicine Isehara Japan Department of Hematology and Oncology Tokai University Hospital Kanagawa Japan Department of Hematology and Oncology, Tokai University, School of Medicine Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan; Neurobehavioral Unit, Central Institute for Experimental Animal, Kawasaki 216–0001, Japan Division of Haematology/Oncology, Department of Internal Medicine Tokai University School of Medicine Isehara Japan Tokai University Hospital Isehara Japan From the Division of Hematology, the Department of Medicine, Tokai University School of Medicine; Research Center for Regenerative Medicine, Tokai University School of Medicine; the Department of Internal Medicine, Keio University School of Medicine; the Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine; Core Research for Evolutional Science and Technology-Japan Science and Technology and Department of Physiology, Keio University School of Medicine, Japan. Institute of Medical Sciences, Tokai University, Isehara, Japan; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Tokai University School of Medicine, Isehara, Japan Central Institute for Experimental Animals (CIEA), Kawasakiku, Kawasaki Tokai University Hospital, Isehara, Japan, Division of Hematology/Medical Oncology, Departments of Medicine, Ophthalmology, Pathology, and Urology, Tokai University School of Medicine, Isehara, Japan Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Hematology, Tokai University School of Medicine, Isehara, Kanagawa, Japan Department of Haematology and Oncology Tokai University School of Medicine Isehara Kanagawa Japan Primate Research Laboratory, Central Institute for Experimental Animals, 1430 Nogawa, Miyamaeku, Kawasaki, 216-0001 Japan. Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Japan; Ken Ohmachi and Kiyoshi Ando, Tokai University; Ukihide Tateishi, Yokohama City University Hospital, Kanagawa; Nozomi Niitsu and Naoki Takahashi, Saitama Medical University International Medical Center, Saitama; Toshiki Uchida and Michinori Ogura, Nagoya Daini Red Cross Hospital, Aichi; Naoto Takahashi, Akita University Hospital, Akita; Naokuni Uike, National Kyushu Cancer Center, Fukuoka; Takashi Terauchi, National Cancer Center; Kensei Tobinai, National Cancer Center Hospital, Tokyo; Mitsuaki Tatsumi,... Hematology and Oncology Department of Hematology and Oncology Tokai University Isehara Japan 2Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara 259-1193, Japan Division of Hematology and Oncology, Tokai University School of Medicine. Division of Hematology/Oncology Department of Internal Medicine, Tokai University, School of Medicine, Setagaya-ku, Japan; Department of Hematology, Tokai University, Kanagawa 259-1193, Japan; Division of Hematopoiesis, Research Center for Regenerative Medicine; Tokai University School of Medicine, Kanagawa, Japan; Department of Hematology; Tokai University School of Medicine, Kanagawa, Japan From the Division of Hematopoiesis, Research Center for Regenerative Medicine, Department of Hematology, and Institute of Medical Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan. Department of Hematology and Oncology School of Medicine Tokai University Kanagawa Japan From the Research Center for Regenerative Medicine and the Department of Hematology, Tokai University, School of Medicine, Isehara, Kanagawa; the BioResource Center, Riken Tsukuba Institute, Ibaraki; and the Department of Industrial Science and Technology, Tokyo University of Science, Noda, Chiba, Japan. Department of Hematology and Oncology, Tokai University, School of Medicine, Isehara, Japan, Department of Hematology Tokai University School of Medicine Isehara Japan Department of Hematology/Oncology, Tokai University School of Medicine , 143, Shimokasuya, Isehara-shi, Kanagawa 259-1193 , Japan; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University , 1-2-3, Kasumi, Minami-ku, Hiroshima-shi, Hiroshima 734-0037 , Japan 22Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Japan Department of Hematology and Oncology Tokai University School of Medicine Kanagawa Japan Division of Hematopoiesis, Research Center for Regenerative Medicine, and Department of Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. andok@keyaki.cc.u-tokai.ac.jp. Department of Hematology and Oncology Tokai University School of Medicine Isehara Japan Department of Hematology and Oncology, Tokai University School of Medicine , Isehara , Japan From the Division of Hematology (H.K., K.A., T.H.) and the Division of Neurology, Department of Medicine (S. Takizawa, Y.M., S. Takagi), Tokai University School of Medicine, and the Center for Regenerative Medicine (H.K., T.T., K.A., T.H.), Tokai University School of Medicine, Isehara, Kanagawa, Japan; the Cardiopulmonary Division (J.F., K.F.), Department of Internal Medicine, and Department of Physiology (H.O.), Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan Department of Hematology and Oncology, Tokai University School of Medicine School Medicine Tokai University Isehara Kanagawa Japan Department of Hematology–Oncology School of Medicine Tokai University Isehara Japan Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Internal Medicine, Division of Hematology/Oncology Department of Hematology and Oncology Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG‐LSG) Tokai University of School of Medicine Isehara Japan Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan Department of Hematology and Oncology, Tokai University, Isehara, Japan, Department of Hematology and Oncology Tokai University Tokyo Japan Japan PNH Study Group Tokyo Japan; Department of Hematology and Oncology Tokai University Tokyo Japan Department of Hematology and Oncology School of Medicine Tokai University Isehara Japan From the Department of Infectious Diseases, Tokai University School of Medicine, Kanagawa, Japan; and the Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. From the Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa; the Department of Hematology, Tokai University School of Medicine, Isehara, Kanagawa; the Central Institute for Experimental Animals, Kawasaki, Kanagawa; the BioResource Center, RIKEN Tsukuba Institute, Tsukuba, Ibaraki; and the Department of Cell Transplantation & Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan. Department of Hematology and Oncology, Tokai University, Isehara, Japan Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan; Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicine, Kanagawa, Japan |
Incoming Links
Total number of triples: 439.